[1] Electromyography and Clinical Neurophysiology Group of Neurology Society for Chinese Medical Association, Neuromuscular Division Neurology Society of Chinese Medical Association. Chinese guidelines for diagnosis and treatment of amyotrophic lateral sclerosis[J]. Zhonghua Shen Jing Ke Za Zhi, 2012, 45:531-533.[中华医学会神经病学分会肌电图与临床神经电生理学组, 中华医学会神经病学分会神经肌肉病学组. 中国肌萎缩侧索硬化诊断和治疗指南[J]. 中华神经科杂志, 2012, 45:531-533.]
[2] Valdmanis PN, Rouleau GA. Genetics of familial amyotrophic lateral sclerosis[J]. Neurology, 2008, 70:144-152.
[3] Boylan K. Familial amyotrophic lateral sclerosis[J]. Neurol Clin, 2015, 33:807-830.
[4] Byrne S, Bede P, Elamin M, Kenna K, Lynch C, McLaughlin R, Hardiman O. Proposed criteria for familial amyotrophic lateral sclerosis[J]. Amyotroph Lateral Scler, 2011, 12:157-159.
[5] Benatar M, Kurent J, Moore DH. Treatment for familial amyotrophic lateral sclerosis/motor neuron disease[J]. Cochrane Database Syst Rev, 2009:CD006153.
[6] Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis[J]. Nature, 1993, 362:59-62.
[7] Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, Patterson V, Swingler R, Kieran D, Prehn J, Morrison KE, Green A, Acharya KR, Brown RH Jr, Hardiman O. ANG mutations segregate with familial and ‘sporadic’ amyotrophic lateral sclerosis[J]. Nat Genet, 2006, 38:411-413.
[8] Paubel A, Violette J, Amy M, Praline J, Meininger V, Camu W, Corcia P, Andres CR, Vourc'h P; French Amyotrophic Lateral Sclerosis (ALS) Study Group. Mutations of the ANG gene in French patients with sporadic amyotrophic lateral sclerosis[J]. Arch Neurol, 2008, 65:1333-1336.
[9] Zou ZY, Zhou ZR, Che CH, Liu CY, He RL, Huang HP. Genetic epidemiology of amyotrophic lateral sclerosis:a systematic review and meta-analysis[J]. J Neurol Neurosurg Psychiatry, 2017, 88:540-549.
[10] Zou ZY, Liu MS, Li XG, Cui LY. The distinctive genetic architecture of ALS in mainland China[J]. J Neurol Neurosurg Psychiatry, 2016, 87:906-907.
[11] Liu ZJ, Lin HX, Wei Q, Zhang QJ, Chen CX, Tao QQ, Liu GL, Ni W, Gitler AD, Li HF, Wu ZY. Genetic spectrum and variability in Chinese patients with amyotrophic lateral sclerosis[J]. Aging Dis, 2019, 10:1199-1206.
[12] Vance C, Rogelj B, Hortobágyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, Ganesalingam J, Williams KL, Tripathi V, Al-Saraj S, Al-Chalabi A, Leigh PN, Blair IP, Nicholson G, de Belleroche J, Gallo JM, Miller CC, Shaw CE. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6[J]. Science, 2009, 323:1208-1211.
[13] Renton AE, Chiò A, Traynor BJ. State of play in amyotrophic lateral sclerosis genetics[J]. Nat Neurosci, 2014, 17:17-23.
[14] Hewitt C, Kirby J, Highley JR, Hartley JA, Hibberd R, Hollinger HC, Williams TL, Ince PG, McDermott CJ, Shaw PJ. Novel FUS/TLS mutations and pathology in familial and sporadic amyotrophic lateral sclerosis[J]. Arch Neurol, 2010, 67:455-461.
[15] DeJesus-Hernandez M, Kocerha J, Finch N, Crook R, Baker M, Desaro P, Johnston A, Rutherford N, Wojtas A, Kennelly K, Wszolek ZK, Graff-Radford N, Boylan K, Rademakers R. De novo truncating FUS gene mutation as a cause of sporadic amyotrophic lateral sclerosis[J]. Hum Mutat, 2010, 31:E1377-1389.
[16] Chiò A, Calvo A, Moglia C, Ossola I, Brunetti M, Sbaiz L, Lai SL, Abramzon Y, Traynor BJ, Restagno G. A de novo missense mutation of the FUS gene in a "true" sporadic ALS case[J]. Neurobiol Aging, 2011, 32:553.
[17] Huang EJ, Zhang J, Geser F, Trojanowski JQ, Strober JB, Dickson DW, Brown RH Jr, Shapiro BE, Lomen-Hoerth C. Extensive FUS-immunoreactive pathology in juvenile amyotrophic lateral sclerosis with basophilic inclusions[J]. Brain Pathol, 2010, 20:1069-1076.
[18] Chen L. FUS mutation is probably the most common pathogenic gene for JALS, especially sporadic JALS[J]. Rev Neurol (Paris), 2020.[Epub ahead of print]
[19] Liu ZJ, Lin HX, Liu GL, Tao QQ, Ni W, Xiao BG, Wu ZY. The investigation of genetic and clinical features in Chinese patients with juvenile amyotrophic lateral sclerosis[J]. Clin Genet, 2017, 92:267-273.
[20] Chen W, Xie Y, Zheng M, Lin J, Huang P, Pei Z, Yao X. Clinical and genetic features of patients with amyotrophic lateral sclerosis in southern China[J]. Eur J Neurol, 2020, 27:1017-1022.
[21] Aoki N, Higashi S, Kawakami I, Kobayashi Z, Hosokawa M, Katsuse O, Togo T, Hirayasu Y, Akiyama H. Localization of fused in sarcoma (FUS) protein to the post-synaptic density in the brain[J]. Acta Neuropathol, 2012, 124:383-394.
[22] Lagier-Tourenne C, Polymenidou M, Cleveland DW. TDP-43 and FUS/TLS:emerging roles in RNA processing and neurodegeneration[J]. Hum Mol Genet, 2010, 19:R46-64.
[23] Kanai Y, Dohmae N, Hirokawa N. Kinesin transports RNA:isolation and characterization of an RNA-transporting granule[J]. Neuron, 2004, 43:513-525.
[24] Yoshimura A, Fujii R, Watanabe Y, Okabe S, Fukui K, Takumi T. Myosin-Va facilitates the accumulation of mRNA/protein complex in dendritic spines[J]. Curr Biol, 2006, 16:2345-2351.
[25] Wang X, Arai S, Song X, Reichart D, Du K, Pascual G, Tempst P, Rosenfeld MG, Glass CK, Kurokawa R. Induced ncRNAs allosterically modify RNA-binding proteins in cis to inhibit transcription[J]. Nature, 2008, 454:126-130.
[26] Law WJ, Cann KL, Hicks GG. TLS, EWS and TAF15:a model for transcriptional integration of gene expression[J]. Brief Funct Genomic Proteomic, 2006, 5:8-14.
[27] Kwiatkowski TJ Jr, Bosco DA, Leclerc AL, Tamrazian E, Vanderburg CR, Russ C, Davis A, Gilchrist J, Kasarskis EJ, Munsat T, Valdmanis P, Rouleau GA, Hosler BA, Cortelli P, de Jong PJ, Yoshinaga Y, Haines JL, Pericak-Vance MA, Yan J, Ticozzi N, Siddique T, McKenna-Yasek D, Sapp PC, Horvitz HR, Landers JE, Brown RH Jr. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis[J]. Science, 2009, 323:1205-1208.
[28] Dodd KC, Power R, Ealing J, Hamdalla H. FUS-ALS presenting with myoclonic jerks in a 17-year-old man[J]. Amyotroph Lateral Scler Frontotemporal Degener, 2019, 20:278-280.
[29] Chen C, Ding X, Akram N, Xue S, Luo SZ. Fused in sarcoma:properties, self-assembly and correlation with neurodegenerative diseases[J]. Molecules, 2019, 24:1622.
[30] Chiò A, Restagno G, Brunetti M, Ossola I, Calvo A, Mora G, Sabatelli M, Monsurrò MR, Battistini S, Mandrioli J, Salvi F, Spataro R, Schymick J, Traynor BJ, La Bella V; ITALSGEN Consortium. Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation[J]. Neurobiol Aging, 2009, 30:1272-1275.
[31] Swetha RG, Ramaiah S, Anbarasu A. R521C and R521H mutations in FUS result in weak binding with Karyopherin β2 leading to amyotrophic lateral sclerosis:a molecular docking and dynamics study[J]. J Biomol Struct Dyn, 2017, 35:2169-2185.
[32] Lai SL, Abramzon Y, Schymick JC, Stephan DA, Dunckley T, Dillman A, Cookson M, Calvo A, Battistini S, Giannini F, Caponnetto C, Mancardi GL, Spataro R, Monsurro MR, Tedeschi G, Marinou K, Sabatelli M, Conte A, Mandrioli J, Sola P, Salvi F, Bartolomei I, Lombardo F, Mora G, Restagno G, Chiò A, Traynor BJ; ITALSGEN Consortium. FUS mutations in sporadic amyotrophic lateral sclerosis[J]. Neurobiol Aging, 2011, 32:550.
[33] Doi H, Okamura K, Bauer PO, Furukawa Y, Shimizu H, Kurosawa M, Machida Y, Miyazaki H, Mitsui K, Kuroiwa Y, Nukina N. RNA-binding protein TLS is a major nuclear aggregate-interacting protein in huntingtin exon 1 with expanded polyglutamine-expressing cells[J]. J Biol Chem, 2008, 283:6489-6500.
[34] Tornin J, Hermida-Prado F, Padda RS, Gonzalez MV, Alvarez-Fernandez C, Rey V, Martinez-Cruzado L, Estupiñan O, Menendez ST, Fernandez-Nevado L, Astudillo A, Rodrigo JP, Lucien F, Kim Y, Leong HS, Garcia-Pedrero JM, Rodriguez R. FUS-CHOP promotes invasion in myxoid liposarcoma through a SRC/FAK/RHO/ROCK -dependent pathway[J]. Neoplasia, 2018, 20:44-56.
[35] Ghanbarpanah E, Kohanpour MA, Hosseini-Beheshti F, Yari L, Keshvari M. Structure and function of FUS gene in prostate cancer[J]. Bratisl Lek Listy, 2018, 119:660-663.
[36] Xiong D, Wu YB, Jin C, Li JJ, Gu J, Liao YF, Long X, Zhu SQ, Wu HB, Xu JJ, Ding JY. Elevated FUS/TLS expression is negatively associated with E-cadherin expression and prognosis of patients with non-small cell lung cancer[J]. Oncol Lett, 2018, 16:1791-1800.